Concurrent administration of donepezil HCl and digoxin: Assessment of pharmacokinetic changes

British Journal of Clinical Pharmacology, Supplement

Volumn 46, Issue 1, 1998, Pages 40-44

  Tiseo, P J ^a   Perdomo, C A ^a   Friedhoff, L T ^a  

^a EISAI INC   (United States)

Author keywords

Acetylcholinesterase inhibitor; Digoxin; Donepezil; Drug drug interaction

Indexed keywords

DIGOXIN; DONEPEZIL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DRUG BLOOD LEVEL; DRUG HALF LIFE; ELECTROCARDIOGRAM; FATIGUE; HEADACHE; HEART CONDUCTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TELEMETRY; VERTIGO;

EID: 0032435194     PISSN: 02643774     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.0460s1040.x     Document Type: Article

References (16)

1. Katzman R, Saitoh T. Advances in Alzheimer's disease. FASEB J 1991; 5: 278-286.
2. Becker RE. Therapy of the cognitive deficit in Alzheimer's disease: the cholinergic system. In Cholinergic Basis for Alzheimer Therapy, eds Becker R, Giacobini E. Boston: Birkhäuser, 1991: 1-30.
3. Giacobini E. Pharmacotherapy of AD: new drugs and novel strategies. In Alzheimer's Disease - Advances in Clinical and Basic Research, eds Corain B, Iqbal K, Nicolini M, Winblad B, Wisniewski HM, Zatta PF. New York: Wiley, 1993: 529-538.
4. Giacobini E. Therapy for Alzheimer's disease: symptomatic or neuroprotective? Mol Neurol 1994; 9: 115-117.
5. Small DH, Michaelson S. Do cholinesterases have functions unrelated to neurotransmission? Today's Life Sci 1995; 7: 24-30.
6. Sugimoto H, Iimura Y, Yamanishi Y, Yamatsu K. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine hydrochloride (E2020) and related compounds. Bioorg Med Chem Lett 1992; 2: 871-876.
7. 14C). J Label Compounds Radiopharm 1989; XXVII: 835-839.
8. Rogers SL, Yamanishi Y, Yamatsu K. E2020 - the pharmacology of a piperidine cholinesterase inhibitor. In Cholinergic Basis for Alzheimer Therapy, eds Becker R, Giacobini E. Boston: Birkhäuser, 1991: 314-320.
9. Sherman K. Pharmacodynamics of oral E2020 and tacrine in humans: novel approaches. In Cholinergic Basis for Alzheimer Therapy, eds Becker R, Giacobini E. Boston: Birkhäuser, 1991: 321-328.
10. Rogers SL, Friedhoff LT. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicenter, randomized, double-blind, placebo-controlled trial. Dementia 1996; 7: 293-303.
11. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT, the Donepezil Study Group. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 1998; 50: 136-145.
12. Rogers SL, Doody RS, Mohs R, Friedhoff LT, the Donepezil Study Group. Donepezil improves cognition and global function in Alzheimer's disease: a 15-week, double-blind, placebo-controlled study. Arch Intern Med 1998; 158: 1021-1031.
13. Roden DM. Antiarrythmic drugs. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edn, eds Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG. New York: McGraw-Hill, 1996: 839-874.
14. Nies AS, Spielberg SP. Principles of Therapeutics. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edn. Eds Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG. New York: McGraw-Hill, 1996: 43-62.
15. Marcus FI. Pharmacokinetic interactions between digoxin and other drugs. J Am Coll Cardiol 1985; 5: 82A-90A.
16. Lee JW, Rogers SL, Friedhoff LT, Stiles MR, Cooper NM. Validation and application of an HPLC method for the determination of 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl] methyl piperidine HCl (E2020) in human plasma. Pharm Res 1992; 9: S350.